You provide the place and we provide the fun and entertainment!
BellaSandra Beautique brings a unique spa and beauty themed entertainment package to your event.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved about 800 elderly men with low testosterone and symptoms associated with this illness, such http://tinyurl.com/zq3zb78 as physical and sexual dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent conflicting findings on testosterone treatment prompted his team to conduct a large systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the United States suffer from low testosterone, which occurs when the body doesn't make enough hormones as a result of a difficulty with the testicles or pituitary gland. This describes somebody's unexpected weight gain, apparent aging and loss of energy.
And many girls have a knee-jerk suspicion that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably remain the status quo for a little while, given the prohibitive cost of running the long term safety studies needed to gain more total FDA acceptance.